Risk factors

Lightbridge expanded its authorized common stock from 25 million to 100 million shares and raised cash reserves to $201.9 million.

LSB Industries faces heightened natural gas cost risks driven by AI data center demand and export pressures. Geopolitical conflicts continue threatening global fertilizer trade routes and commodity pricing.

Goodwill impairment of $411.9 million in early 2025 drove a new risk disclosure. Merger integration and SWM-Neenah combination risks were dropped. Environmental laws and international trade disclosures were updated.

MBIA faces substantial debt obligations across notes and investment agreements, updating specific figures for 2025. Regulatory oversight, tax law dependencies, and internal controls dominate the risk profile.

Client concentration metrics updated: the company had 254 clients paying $1 million or more in 2025 compared to 241 in 2024.

Ramaco expanded its risk disclosures to heavily feature its new rare earth elements initiative at the Brook Mine. The company highlighted increased exposure to short-term coal pricing and evolving federal climate regulations.

Tariffs, persistent inflation, and supply-chain energy costs now receive more explicit attention because they may pressure portfolio-company margins.

Insurance capital risks now emphasize equity-market declines and potential rating downgrades affecting regulatory capital, liquidity, and borrowing costs.

Interest rate fluctuations heavily impact commercial real estate transaction volumes and company revenues.

Partner United Therapeutics may prioritize its new Tresmi drug over Tyvaso DPI, hurting revenues.

DoW transactions add funding, accounting, customer-delivery, commodity-price protection, and debt-covenant risks.

Increased focus on alternative fuels and hydrogen threatening liquid transportation fuel demand.